豚ワクチン市場：適応症別、技術別、エンドユーザー別-2025-2030年の世界予測

豚ワクチン市場は、2023年に17億1,000万米ドルと評価され、2024年には18億2,000万米ドルに達すると予測され、CAGR 6.72％で成長し、2030年には27億米ドルになると予測されています。

豚ワクチン市場は、豚を伝染病から守り、牛群の健康と生産性を向上させるワクチンの開発、生産、流通を包括しています。このようなワクチンの必要性は、疾病の発生による養豚産業の経済的損失を防ぐ必要性によってもたらされます。これらのワクチンは、豚サーコウイルス、豚繁殖・呼吸器症候群ウイルス（PRRSV）などの病原体を対象に、様々な年齢層の豚に注射または経口投与されます。最終用途には主に動物病院、農場、研究機関が含まれます。市場成長は、豚肉消費量の増加、動物の健康に対する意識の高まり、ワクチン技術の進歩に大きく影響されています。遺伝子組み換えワクチンやDNAワクチンなど、遺伝子工学やバイオテクノロジーにおける最近の技術革新は、有利な機会を提供します。企業は、より効果的で投与しやすいワクチンの研究開発に投資することで、これらを活用することができます。さらに、有機農法や持続可能な農法を目指す傾向が強まっていることから、そうした基準に適合したワクチンの需要も高まっています。しかしながら、承認プロセスを遅らせる厳しい規制の枠組み、高い開発コスト、発展途上地域における限られた認知度と入手可能性などの制約があります。また、ワクチンの保管や流通のロジスティックスにも課題があり、世界的に豚が飼育されている気候が多様であることから、特に複雑である可能性があります。さらに、新しい病原体の出現や株の変化により、ワクチン製剤の継続的な研究と適応の必要性が強調されています。技術革新の焦点は、ワクチンの有効性と免疫持続期間の強化、および1回の投与で複数の疾病に対処できる多機能ワクチンの開発です。ワクチン送達のためのナノテクノロジーや、病原体耐性のある遺伝子組み換えブタの調査も、潜在的な可能性を示しています。市場競争は激しく、生物学的解決策への着実な移行が見られるなど、市場はダイナミックです。

市場力学：急速に進化する豚ワクチン市場の主要市場インサイトを公開

豚ワクチン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の豚疾病の流行増加
  • 高品質豚肉への需要の高まり
  • 動物の健康を支援する政府の取り組み
• 市場抑制要因
  • 豚ワクチン開発コストの高騰と複雑な保管問題
• 市場機会
  • 豚ワクチンの技術的進歩
  • 新規豚ワクチン製造のための有利な投資環境
• 市場の課題
  • 豚ワクチンに関連する副作用とともに、限られた入手可能性と認知度

ポーターのファイブフォース：豚ワクチン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、豚ワクチン市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：豚ワクチン市場における外部からの影響の把握

外部マクロ環境要因は、豚ワクチン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：豚ワクチン市場における競合情勢の把握

豚ワクチン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス：豚ワクチン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、豚ワクチン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で豚の病気の蔓延が増加
    • 高品質の豚肉の需要増加
    • 動物の健康を支援する政府の取り組み
  • 抑制要因
    • 豚ワクチン開発の高コストと複雑な保管問題
  • 機会
    • 豚ワクチンの技術的進歩
    • 小説の制作に有利な投資情勢豚ワクチン
  • 課題
    • 豚ワクチンに関連する副作用とともに、入手性および認知度の制限
• 市場セグメンテーション分析
  • テクノロジー：遺伝子工学と分子生物学技術の進歩により、組み換えワクチンの革新が進む
  • エンドユーザー：豚生産農場における集団ワクチン接種プログラムの必要性の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 豚ワクチン市場適応症別

• 関節炎
• 下痢
• 豚サーコウイルス関連疾患
• 豚繁殖呼吸器症候群
• 豚インフルエンザ

第7章 豚ワクチン市場：技術別

• 結合ワクチン
• DNAワクチン
• 不活化ワクチン
• 生弱毒化ワクチン
• 組み換えワクチン
• トキソイドワクチン

第8章 豚ワクチン市場：エンドユーザー別

• 養豚農場
• 獣医クリニック/病院

第9章 南北アメリカの豚ワクチン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の豚ワクチン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの豚ワクチン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ゾエティス、サーコマックスを英国で発売
  • メルクアニマルヘルス、3-in-1豚ワクチンを発売
  • エランコはアプティミューンのPRRS不活化自家ワクチンの米国独占販売代理店です

企業一覧

• Bayer AG
• Endovac Animal Health
• Merck & Co., Inc.
• FATRO S.p.A.
• Malaysian Vaccines & Pharmaceuticals Sdn Bhd.
• Yenher Agro-Products Sdn. Bhd.
• Boehringer Ingelheim International GmbH
• Biogenesis Bago S.A.
• Formosa Biomedical Inc.
• Indian Immunologicals Ltd.
• Kyoto Biken Laboratories, Inc.
• PBS Animal Health
• Bimeda Holdings PLC
• HIPRA, S.A.
• Zoetis Inc.
• Aptimmune Biologics, Inc.
• AVAC Vietnam Joint Stock Company
• Eli Lilly and Company
• Phibro Animal Health Corporation
• Arko Laboratories
• Genvax Technologies, Inc.
• Nisseiken Co., Ltd.
• Medgene Labs
• Virbac SA
• Ceva Sante Animale
• KM Biologics Co., Ltd.

LIST OF FIGURES

• FIGURE 1. PORCINE VACCINES MARKET RESEARCH PROCESS
• FIGURE 2. PORCINE VACCINES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PORCINE VACCINES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PORCINE VACCINES MARKET DYNAMICS
• TABLE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PORCINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PORCINE VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PORCINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PORCINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PORCINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PORCINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PORCINE VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PORCINE VACCINES MARKET SIZE, BY HOG/PIG PRODUCTION FARM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PORCINE VACCINES MARKET SIZE, BY VETERINARY CLINICS/HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. CANADA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. CHINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. CHINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. CHINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. INDIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. INDIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. ITALY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. ITALY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. ITALY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. POLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. POLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. POLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. QATAR PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. QATAR PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. QATAR PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

The Porcine Vaccines Market was valued at USD 1.71 billion in 2023, expected to reach USD 1.82 billion in 2024, and is projected to grow at a CAGR of 6.72%, to USD 2.70 billion by 2030.

The porcine vaccines market encompasses the development, production, and distribution of vaccines used to protect pigs from infectious diseases, thereby enhancing herd health and productivity. The necessity for such vaccines is driven by the need to prevent economic losses in the swine industry due to disease outbreaks. These vaccines are applied via injection or oral administration to pigs of various age groups, targeting pathogens like Porcine Circovirus, Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), and others. End-use scope primarily includes veterinary clinics, farms, and research institutions. Market growth is significantly influenced by rising pork consumption, increased awareness of animal health, and advancements in vaccine technology. Recent innovations in genetic and biotechnology such as recombinant vaccines and DNA vaccines offer lucrative opportunities. Companies can capitalize on these by investing in R&D for more effective and easy-to-administer vaccines. Additionally, the growing trend towards organic and sustainable farming practices highlights the demand for vaccines that comply with such standards. However, limitations include stringent regulatory frameworks that slow down the approval process, high development costs, and limited awareness and accessibility in developing regions. Challenges also arise from vaccine storage and distribution logistics, which can be particularly complex given the diverse climates in which swine are raised globally. Furthermore, the emergence of new pathogens and changing strains emphasize the need for continuous research and adaptation in vaccine formulation. Innovation can focus on enhancing the efficacy and duration of immunity of vaccines, as well as developing multifunctional vaccines that can combat multiple diseases in a single dose. Research into nanotechnology for vaccine delivery and pathogen-resistant genetically modified pigs also presents potential avenues. The market is dynamic with intense competition, witnessing a steady shift towards biologic solutions-a trend that market players must monitor to harness upcoming opportunities effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Porcine Vaccines Market

The Porcine Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in Prevalence of Swine Diseases Worldwide
  • Increasing Demand for High-Quality Pork Meat
  • Government Initiatives to Support Animal Health
• Market Restraints
  • High Cost of Porcine Vaccine Development and Complex Storage Issues
• Market Opportunities
  • Technological Advancements in Porcine Vaccine
  • Favorable Investment Landscape For Production of Novel Porcine Vaccines
• Market Challenges
  • Limited Availability and Awareness Along with Side Effects Associated with Porcine Vaccines

Porter's Five Forces: A Strategic Tool for Navigating the Porcine Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Porcine Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Porcine Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Porcine Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Porcine Vaccines Market

A detailed market share analysis in the Porcine Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Porcine Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Porcine Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Porcine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Endovac Animal Health, Merck & Co., Inc., FATRO S.p.A., Malaysian Vaccines & Pharmaceuticals Sdn Bhd., Yenher Agro-Products Sdn. Bhd., Boehringer Ingelheim International GmbH, Biogenesis Bago S.A., Formosa Biomedical Inc., Indian Immunologicals Ltd., Kyoto Biken Laboratories, Inc., PBS Animal Health, Bimeda Holdings PLC, HIPRA, S.A., Zoetis Inc., Aptimmune Biologics, Inc., AVAC Vietnam Joint Stock Company, Eli Lilly and Company, Phibro Animal Health Corporation, Arko Laboratories, Genvax Technologies, Inc., Nisseiken Co., Ltd., Medgene Labs, Virbac SA, Ceva Sante Animale, and KM Biologics Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Porcine Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Indication, market is studied across Arthritis, Diarrhea, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, and Swine Influenza.
• Based on Technology, market is studied across Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines, Live attenuated Vaccines, Recombinant Vaccines, and Toxoid Vaccines.
• Based on End User, market is studied across Hog/Pig Production Farm and Veterinary Clinics/Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in Prevalence of Swine Diseases Worldwide
    • 5.1.1.2. Increasing Demand for High-Quality Pork Meat
    • 5.1.1.3. Government Initiatives to Support Animal Health
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost of Porcine Vaccine Development and Complex Storage Issues
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological Advancements in Porcine Vaccine
    • 5.1.3.2. Favorable Investment Landscape For Production of Novel Porcine Vaccines
  • 5.1.4. Challenges
    • 5.1.4.1. Limited Availability and Awareness Along with Side Effects Associated with Porcine Vaccines
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Growing innovations in recombinant vaccines due to advancements in genetic engineering and molecular biology technologies
  • 5.2.2. End User: Growing need for mass vaccination programs in the hog/pig production farm
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Porcine Vaccines Market, by Indication

• 6.1. Introduction
• 6.2. Arthritis
• 6.3. Diarrhea
• 6.4. Porcine Circovirus Associated Disease
• 6.5. Porcine Reproductive & Respiratory Syndrome
• 6.6. Swine Influenza

7. Porcine Vaccines Market, by Technology

• 7.1. Introduction
• 7.2. Conjugate Vaccines
• 7.3. DNA Vaccines
• 7.4. Inactivated Vaccines
• 7.5. Live attenuated Vaccines
• 7.6. Recombinant Vaccines
• 7.7. Toxoid Vaccines

8. Porcine Vaccines Market, by End User

• 8.1. Introduction
• 8.2. Hog/Pig Production Farm
• 8.3. Veterinary Clinics/Hospitals

9. Americas Porcine Vaccines Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Porcine Vaccines Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Porcine Vaccines Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Zoetis Launches Circomax In The UK
  • 12.3.2. Merck Animal Health Launches 3-In-One Swine Vaccine
  • 12.3.3. Elanco is Exclusive U.S. Distributor of Aptimmune's PRRS Killed Autogenous Vaccine

Companies Mentioned

• 1. Bayer AG
• 2. Endovac Animal Health
• 3. Merck & Co., Inc.
• 4. FATRO S.p.A.
• 5. Malaysian Vaccines & Pharmaceuticals Sdn Bhd.
• 6. Yenher Agro-Products Sdn. Bhd.
• 7. Boehringer Ingelheim International GmbH
• 8. Biogenesis Bago S.A.
• 9. Formosa Biomedical Inc.
• 10. Indian Immunologicals Ltd.
• 11. Kyoto Biken Laboratories, Inc.
• 12. PBS Animal Health
• 13. Bimeda Holdings PLC
• 14. HIPRA, S.A.
• 15. Zoetis Inc.
• 16. Aptimmune Biologics, Inc.
• 17. AVAC Vietnam Joint Stock Company
• 18. Eli Lilly and Company
• 19. Phibro Animal Health Corporation
• 20. Arko Laboratories
• 21. Genvax Technologies, Inc.
• 22. Nisseiken Co., Ltd.
• 23. Medgene Labs
• 24. Virbac SA
• 25. Ceva Sante Animale
• 26. KM Biologics Co., Ltd.